Ohio State Navbar

Sign In

RSS Feed Regenerative Medicine News

Pluristem Achieves Milestone Towards Completion of its New GMP Manufacturing Facility for Commercial Production of PLX Cells 



October 23, 2012 - (Pluristem) - "Pluristem Therapeutics, Inc., a leading developer of placenta-based cell therapies, announced today a milestone in the build-out of its new clinical Good Manufacturing Process (cGMP) manufacturing facility for its Placental eXpanded (PLX) cells in MATAM Park, Haifa, Israel. Pluristem has initiated the Installation Qualification (IQ) validation process through Biopharmax Group Ltd., the company which is handling the build-out of Pluristem’s facility." Read Full Article


Posted on 13-Nov-12 by Gallerno, Jacob
Tags: Science and Industry News
Trackback Url  |  Link to this post | Bookmark this post with: